Combination of mitoxantrone and etoposide in patients aged over 60 years with untreated acute myelogenous leukemia.
Ehninger
G
G
Department of Internal Medicine, University of Tübingen, FRG.
Fackler-Schwalbe
E
E
Freund
M
M
Heil
G
G
Henke
M
M
Hoelzer
D
D
Hoffmann
R
R
Kurrle
E
E
Link
H
H
Lösch
A
A
D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D001855:Bone Marrow Diseases / Q000139:chemically induced; D005047:Etoposide / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D015479:Leukemia, Myelomonocytic, Acute / Q000188:drug therapy*; D008875:Middle Aged; D008942:Mitoxantrone / Q000008:administration & dosage / Q000009:adverse effects; D015337:Multicenter Studies as Topic
D005047:Etoposide; D008942:Mitoxantrone